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Abstract. Obesity is associated with a high risk of developing diabetes and cardiovascular 
diseases. Therefore, management of body weight to prevent obesity remains as an important priority. 
The present investigation addresses the effects of Omega-3 PUFAs on body weight, blood 
composition and histological aspects in guinea pigs. We used 21 Guinea pigs, 12 weeks old, which 
were randomly assigned to control group, 0.5 % cholesterol in diet group and 0.5 % cholesterol in diet 
plus Omega-3 group. Guinea pigs fed with 0.5 % cholesterol in diet showed a significant increase in 
body weight and serum levels – total cholesterol (TC), triglycerides (TG) and LDL cholesterol (LDL-
C) – when compared to control group (P=0.0039, P=0.00950, P=0.00001, P= 0.00134 respectively). 
They also develop severe hepatic steatosis. Adding Omega-3 in diet significant reduce body weight, 
serum levels – TC, TG and LDL-C and hepatic steatosis when compared to control group (P=0.04077, 
P= 0.01, P=0.00001, P=0.0995). In conclusion, concerning the efficacy of Omega-3 fatty acids to 
reduce body weight, hypertriglyceridemia and hepatic steatosis, their adding in diet have positive 
effects in obesity prevention.  
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INTRODUCTION 
 
Many studies in rodents have demonstrated that PUFA, especially n-3 PUFA EPA 
(20:5n-3) and DHA (22:6n-3), which are abundant in marine fish oils, are less effective in 
promoting accumulation of adipose tissue than saturated fats (Takahashi and Ide, 1999; 
Azain, 2004; Raclot et al, 1997.). Dietary n-3 PUFA admixed to high-fat (HF) diets do not 
affect food consumption (Ikemoto et al, 1996; Hun et al, 1999; Oudart et al, 1997), but they 
do modulate fuel partitioning by down regulating lipogenesis and stimulating lipid oxidation. 
However, the mechanism for the reduction of body fat stores is still unclear (Lapillonne et al, 
2004). Both in animals (Raclot and Oudart, 1999) and humans (Ruxton et al, 2004; Mori et al, 
1999), EPA/DHA lower blood TG and may improve insulin sensitivity. Collectively, these 
benefits resulted in a decline of excess fat building up in the liver – preventing the very 
serious metabolic problem of fatty liver known as NASH (nonalcoholic 
steatohepatitis) (Byron, 2009). 
Also studies in mice fed semisynthetic high fat diets have documented the reduction of 
adiposity by n-3 PUFA (Cha et al, 2001; Tsuboyama-Kasaoka et al, 1999) and indicated that 
EPA and DHA could be more effective than n-3 PUFA of plant origin, that is, a-linolenic acid 
(ALA, 18:3 n-3). The goal of this study was to learn whether EPA and DHA could limit the 
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obesity and proliferation of adipose tissue cells induced in the C57BL/6J mice by the 
composite high fat diet. 
The aim of this work consists in study the possibilities to identify functional food 
models to prove functional methods in human, using animals experimental techniques, 
consisting in obesity induction through cholesterol and its prevention using dietary 
supplements with Omega-3 fatty acids.  
 
MATERIALS AND METHODS 
 
 Materials 
Concentrated fish oil was extracted from Omacor capsules (Pronova, Norway), 
cholesterol was obtained from sheep wool powder, ~95% (GC), (Sigma-Aldrich), and the 
standard chow for Guinea pigs was obtained from Pannonmill Takarmany Kft., Hungary. 
 Animals and diets 
Twenty-one male Guinea pigs, 3 months old were placed on 1 of 3 groups: control 
group fed with a standard chow, high fat group fed with 0.5 % cholesterol in diet and Omega-
3 group fed with 0.5 % cholesterol plus 0.6 mg/kg Omega-3 PUFA in diet. The animals were 
housed in cages and maintained in a temperature-controlled room on a 12:12-h dark–light 
cycle for 8 weeks. The body weight was measured once at two weeks and serum parameters 
were determined at baseline and after 4 and 8 weeks. At the end of the 8 weeks, animals were 
sacrificed for histological slides.  
Serum determinations 
Fasting serum samples were obtained for cholesterol and triglyceride determinations at 
baseline and after 4 and 8 weeks on the experimental diet. The blood was collected from the 
retro orbicular sinus in serum separator tubes, and centrifuged immediately. Serum was then 
stored at 0-4 °C until analysis. The samples were analyzed with Konelab 20i clinical 
chemistry analyzer.  
Anatomopathological aspects 
After 12 weeks on experimental diets, Guinea pigs were sacrificed. The liver was 
removed and prepared for histological procedures. Olympus CX41 microscope with camera 
was used for microscopic exam. 
 Statistical analysis 
Data are presented as mean values. Statistical significance of experimental 
observations was determined by one-way analysis of variance (ANOVA), with the level of 
significance set at P<0.05. 
 
RESULTS AND DISCUSSIONS 
 
 Body weight  
At the control group, during the eight weeks of study, it could be observed an increase 
in body weight, which was physiological due to upgrowing animal’s age (3 months). The 
positive group presented a significant increase in body weight (p=0.0039) compared to 
control group, due to the constant administration of cholesterol in diet. Comparative, it can be 
observed that the mean weight at these groups have an ascendant direction, but the weight 
gain of the positive group in higher than at the control group (134.4 g vs 117.8 g). Significant 
differences (p=0.04077) were also obtained in what concerns weight gain at Omega-3 group.  
Even if the animal’s diet was enriched with 0.5% cholesterol, the supplementation of diet with 
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Omega- 3 polyunsaturated fatty acids in dose of 0.6 mg/kg had an influence on their weight 
thus, the weight gain of this group was of 49.6 g (Tab. 1).  
Tab. 1 
Body weight evolution at guinea pigs 
 
 Baseline 2nd week 4th week 6th week 8th week Weight gain 
Control 
group 
414.2 471.8 499.6 504.2 532 117.8 
High fat diet 
group 
441.4 467.8 517 538 576 134.4 
Omega-3 
group 
459.4 447.4 471.4 495 509 49.6 
* Values are given as mean, in grams 
Serum parameters  
The data from biochemical determination are presented in table no 2. The values of the 
control group are ranging between the minimum and maximum limits of this specie (TC: 20-
80 mg/dl, TG: 0-125 mg/dl, LDL-C: 35-70 mg/dl and HDL-C: 5-20 mg/dl).  
At positive group it can be observed that at the 2nd and the 3rd determination, the total 
cholesterol (89.5 mg/dl and 89 mg/dl) and triglyceride’s (129 mg/dl and 169.5 mg/dl) values 
are not ranging between normal limits, exceeding the maximum value, which is due to 
administration of successive doses of cholesterol. A low HDL-C level (4 mg / dl at baseline 
and 9 mg / dl in the 8th week) is also a factor of major cardiovascular risk, independent of 
other lipid fractions, but also a risk factor that contributes to the changing of the LDL-C 
therapeutic targets whose values are increasing, reaching the value of 47 mg / dl. From 
biochemical results, it can be sustained that the positive group is proned to cardiovascular 
diseases, which are in direct relationship with obesity. Statistical analysis indicate a 
significant increase in total cholesterol (P=0.00950), triglycerides (P=0.00001) and LDL 
cholesterol (P= 0.00134) when compared to control group. 
. Tab. 2 
The evolution of biochemical parameters 
 
Total cholesterol Triglycerides Group 
Baseline 4th week 8th week Baseline 4th week 8th week 
Control group 51 58.5 65 82 91 120 
High fat diet 
group 
48 89.5 89 88 129 169,5 
Omega-3 
group 
53 44 56 85 46.5 40 
 
LDL cholesterol HDL cholesterol Group 
Baseline 4th week 8th week Baseline 4th week 8th week 
Control group 48 42 52 6 17 19 
High fat diet 
group 
36 47.5 47 4 8 9 
Omega-3 
group 
40 34.5 39 9 7.5 15 
* Values are given as mean, in mg/dl 
The Omega- 3 group biochemical parameter’s evolution is favorable from value’s 
point of view. It can be observed a decrease of TG value at the third determination (40 mg/dl) 
beside baseline (85 mg/dl). The literature cites that in patients receiving a food supplement 
with Omega- 3 fatty acids, decreases the amount of triglycerides up to 38% (Schmidt et al, 
1990). The average value of HDL cholesterol is continuing to increase in all three 
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determinations from 9 mg/dl to 15 mg/dl in the 8th week. The HDL-cholesterol (HDL-C), a 
classical parameter of lipid balance, used among with the total cholesterol (TC), the 
triglycerides (TG) and the LDL cholesterol (LDL-C) is an influent factor of cardiovascular 
risk. Many epidemiological studies showed a positive correlation between the HDL-C level 
and cardiovascular protection, its increasing concentration being an important therapeutic 
objective. For this purpose it is important to understand the HDL-C’s role in organism and 
point out the favorable and unfavorable factors which may influence this circulating 
lipoprotein fraction. The LDL-C values remain almost constant. Compared to control group, 
there is a significant decrease in TC (P= 0.01), TG (P=0.00001) and LDL-C (P=0.0995).  
Anatomopathological lesions 
At the control group it couldn’t be observed any macroscopic alteration that can 
indicate obesity. At the sacrification, all organs showed normal structure, without 
modifications, perirenal and retroperitoneal adipose tissues being in normal quantities. The 
liver presented a normal aspect (fig. 1). Microscopically it can be seen the specific liver 
structure and arrangement of the Remak columns converging toward the centrolobular vein. 
The hepatocytes have a normal shape and structure without alterations in the nucleus or 
cytoplasm (fig. 2). 
 
 
Fig. 1. Liver with a normal aspect, control group Fig. 2. Liver with a specific histological structure 
control group, HE, 100X 
 
Macroscopic changes from positive group could be seen on the surface of the liver and 
profoundly. Thus, the liver was enlarged, with rounded margins, yellowish color, with 
obvious lobulation, friable (fig. 3). The presented changes are correlated with a high intake of 
cholesterol. 
The histological slides from the positive group presented significant histological 
modifications. In the liver it can be noticed the diffuse hepatosteatosis dystrophy, with large 
drops, that affects the hepatic lobule almost entirely, with the exception of the lobule 
periphery, where hepatic cells are less affected. The degenerative process begun from 
centrolobular vein, fact that note that the dystrophy intervened through venous path (fig. 4).  
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Fig. 3. Fatty liver,  positive group Fig. 4. Liver, hepatosteatosis diffuse, with large drops, 
positive group, HE, 200X 
 
In some areas it can be seen the lipid cysts formation (red arrow), characterized by an 
elongated shape, clear, which appear because of the merging of some lipid vacuoles and the 
degeneration of the cellular membrane. Also, the cells in different stages of necrosis (green 
arrow) can be seen, some of which presenting an acidophilic cytoplasm and picnotic nuclei, 
and others in a cytolysis stage, respectively cellular lysis (fig. 5, fig. 6). 
  
 
Fig. 5. Liver, acidophilic corpuscles, positive group, 
HE, 200X                                
Fig. 6. Liver, lipid cysts formation, positive group, HE, 
400X 
  
 At Omega-3 group, the liver had a normal aspect, dark-red-brown color, non-friable, 
(fig. 7). The lobulation couldn’t be observed.  
 Microscopically it can be seen the lipid dystrophy with small drops (pink arrow) 
situated in the surroundings of the centrolobular vein as well as some areas with lipid 
dystrophy with large drops. Also one can see areas in which the liver’s cell architecture does 
not present alterations (fig. 8). In contrast to the positive group where it was found this kind 
of lipid dystrophy, it can be noticed the fact that here the degenerative process is of a lower 
intensity and smaller extension. Therefore it can be deduced that in the case of Omega – 3 
group, the fatty acids administration have a certain protection, but not totally.                                               
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CONCLUSIONS 
 
1. The administration of a hyperlipidic diet (with 0.5% cholesterol), modify guinea pig’s 
body weight with 37.5%. 
2. High amounts of dietary cholesterol determine the increase of the biochemical parameters 
involved in the cardiovascular pathogenesis, especially the total cholesterol and the 
triglycerides. 
3. The administration of 0.5% adding of cholesterol in the diet on a long term determines the 
morphologic alterations in the liver expressed through degenerative lesions of the 
hepatocytes – hepatosteatosis diffuse with large drops.  
4. A daily dose of 0.6 mg/kg Omega- 3 cancel the effect of dietary cholesterol concerning 
the body weight, the animals from Omega- 3 group being at the same weight as those 
from the control group. 
5. In what concerns the biochemical parameters, Omega – 3 influences clearly in the most 
obvious way the level of the triglycerides in decreasing their levels with 16.43%. 
6. The hepatic protection in the case of supplementation the diet high in cholesterol with 
Omega- 3 is not totally assured, fact proved by the presence of small drops steatosis. 
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